Anticoagulant effects of Idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trials

Author： Harenberg Job  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.64, Iss.6, 2008-06, pp. : 555-563

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Idraparinux effective, but risky, for venous thromboembolism

By  

Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Extended Anticoagulation Therapy for the Primary and Secondary Prevention of Venous Thromboembolism

By Blanchard Elizabeth   Ansell Jack  

Drugs, Vol. 65, Iss. 3, 2005-01 ,pp. : 303-311

Adis International

Access to resources Recommend Favorite

Direct Thrombin Inhibitors for the Prevention of Venous Thromboembolism after Major Orthopaedic Surgery

By  

Current Pharmaceutical Design, Vol. 11, Iss. 30, 2005-11 ,pp. : 3885-3891

Bentham Science Publishers

Access to resources Recommend Favorite

Apixaban: A Review of its Use in the Prevention of Venous Thromboembolism After Knee or Hip Replacement Surgery

By Deeks Emma D.  

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1271-1291

Adis International

Access to resources Recommend Favorite

Dabigatran Etexilate: A Review of its Use for the Prevention of Venous Thromboembolism after Total Hip or Knee Replacement Surgery

By Burness Celeste B.   McKeage Kate  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 963-986

Adis International

Access to resources Recommend Favorite